Masanari Kuwabara1,2,3, Remi Kuwabara4, Ichiro Hisatome5, Koichiro Niwa3, Carlos A Roncal-Jimenez1, Petter Bjornstad1,6, Ana Andres-Hernando1, Yuka Sato1, Thomas Jensen1, Gabriela Garcia1, Minoru Ohno2, James O Hill7, Miguel A Lanaspa1, Richard J Johnson1. 1. Division of Renal Diseases and Hypertension, School of Medicine, University of Colorado Denver, Aurora, Colorado, USA. 2. Department of Cardiology, Toranomon Hospital, Tokyo, Japan. 3. Cardiovascular Center, St. Luke's International Hospital, Tokyo, Japan. 4. Department of Pediatrics, Nihon University, Tokyo, Japan. 5. Division of Regenerative Medicine and Therapeutics, Tottori University Graduate School of Medical Sciences, Tottori, Japan. 6. Children's Hospital Colorado and Barbara Davis Center for Childhood Diabetes, Aurora, Colorado, USA. 7. Colorado Nutrition Obesity Research Center (NORC), University of Colorado, Aurora, Colorado, USA.
Abstract
OBJECTIVE: Whether obesity without metabolic syndrome (i.e., "metabolically healthy" obesity) confers similar or less metabolic risk remains controversial. METHODS: A retrospective 5-year cohort study of 9,721 Japanese subjects (48.5 ± 10.5 years, 4,160 men) was conducted in 2004 and reevaluated 5 years later. Subjects were excluded if they were hypertensive or diabetic or were receiving medications for dyslipidemia and/or gout or hyperuricemia in 2004. Study subjects were categorized according to baseline BMI ≥ 25 kg/m2 (overweight/obesity) and < 25 kg/m2 (lean/normal weight) and also whether they had metabolic syndrome. The cumulative incidence of hypertension and diabetes over 5 years between groups was assessed. A second analysis evaluated whether baseline hyperuricemia provided additional risk. RESULTS: Subjects with overweight/obesity but without metabolic syndrome carried increased cumulative incidence of hypertension (14.6% vs. 7.2%, P < 0.001) and diabetes (2.6% vs. 1.1%, P = 0.004) over 5 years compared to lean/normal subjects without metabolic syndrome. Overweight/obesity conferred an increased risk for diabetes even in individuals with normal fasting blood glucose. Hyperuricemia became an independent risk factor for developing hypertension over 5 years in lean/normal subjects without metabolic syndrome. A 1 mg/dL increase in serum uric acid carried increased risk for hypertension (19%) and diabetes (27%). CONCLUSIONS: Metabolically healthy obesity and hyperuricemia confer increased risk for hypertension and diabetes.
OBJECTIVE: Whether obesity without metabolic syndrome (i.e., "metabolically healthy" obesity) confers similar or less metabolic risk remains controversial. METHODS: A retrospective 5-year cohort study of 9,721 Japanese subjects (48.5 ± 10.5 years, 4,160 men) was conducted in 2004 and reevaluated 5 years later. Subjects were excluded if they were hypertensive or diabetic or were receiving medications for dyslipidemia and/or gout or hyperuricemia in 2004. Study subjects were categorized according to baseline BMI ≥ 25 kg/m2 (overweight/obesity) and < 25 kg/m2 (lean/normal weight) and also whether they had metabolic syndrome. The cumulative incidence of hypertension and diabetes over 5 years between groups was assessed. A second analysis evaluated whether baseline hyperuricemia provided additional risk. RESULTS: Subjects with overweight/obesity but without metabolic syndrome carried increased cumulative incidence of hypertension (14.6% vs. 7.2%, P < 0.001) and diabetes (2.6% vs. 1.1%, P = 0.004) over 5 years compared to lean/normal subjects without metabolic syndrome. Overweight/obesity conferred an increased risk for diabetes even in individuals with normal fasting blood glucose. Hyperuricemia became an independent risk factor for developing hypertension over 5 years in lean/normal subjects without metabolic syndrome. A 1 mg/dL increase in serum uric acid carried increased risk for hypertension (19%) and diabetes (27%). CONCLUSIONS: Metabolically healthy obesity and hyperuricemia confer increased risk for hypertension and diabetes.
Authors: Laurence S Sperling; Jeffrey I Mechanick; Ian J Neeland; Cynthia J Herrick; Jean-Pierre Després; Chiadi E Ndumele; Krishnaswami Vijayaraghavan; Yehuda Handelsman; Gary A Puckrein; Maria Rosario G Araneta; Quie K Blum; Karen K Collins; Stephen Cook; Nikhil V Dhurandhar; Dave L Dixon; Brent M Egan; Daphne P Ferdinand; Lawrence M Herman; Scott E Hessen; Terry A Jacobson; Russell R Pate; Robert E Ratner; Eliot A Brinton; Alan D Forker; Laura L Ritzenthaler; Scott M Grundy Journal: J Am Coll Cardiol Date: 2015-09-01 Impact factor: 24.094
Authors: Masanari Kuwabara; Koichiro Niwa; Ichiro Hisatome; Takahiko Nakagawa; Carlos A Roncal-Jimenez; Ana Andres-Hernando; Petter Bjornstad; Thomas Jensen; Yuka Sato; Tamara Milagres; Gabriela Garcia; Minoru Ohno; Miguel A Lanaspa; Richard J Johnson Journal: Hypertension Date: 2017-04-10 Impact factor: 10.190
Authors: Rachel P Wildman; Paul Muntner; Kristi Reynolds; Aileen P McGinn; Swapnil Rajpathak; Judith Wylie-Rosett; MaryFran R Sowers Journal: Arch Intern Med Date: 2008-08-11
Authors: Lara L Roberson; Ehimen C Aneni; Wasim Maziak; Arthur Agatston; Theodore Feldman; Maribeth Rouseff; Thinh Tran; Michael J Blaha; Raul D Santos; Andrei Sposito; Mouaz H Al-Mallah; Ron Blankstein; Matthew J Budoff; Khurram Nasir Journal: BMC Public Health Date: 2014-01-08 Impact factor: 3.295
Authors: Masanari Kuwabara; Ichiro Hisatome; Carlos A Roncal-Jimenez; Koichiro Niwa; Ana Andres-Hernando; Thomas Jensen; Petter Bjornstad; Tamara Milagres; Christina Cicerchi; Zhilin Song; Gabriela Garcia; Laura G Sánchez-Lozada; Minoru Ohno; Miguel A Lanaspa; Richard J Johnson Journal: PLoS One Date: 2017-01-12 Impact factor: 3.240
Authors: Masanari Kuwabara; Mehmet Kanbay; Koichiro Niwa; Ryusuke Ae; Ana Andres-Hernando; Carlos A Roncal-Jimenez; Gabriela Garcia; Laura Gabriela Sánchez-Lozada; Bernardo Rodriguez-Iturbe; Ichiro Hisatome; Miguel A Lanaspa; Richard J Johnson Journal: Nutrients Date: 2020-05-14 Impact factor: 5.717
Authors: Bagas Suryo Bintoro; Yen-Chun Fan; Chia-Chi Chou; Kuo-Liong Chien; Chyi-Huey Bai Journal: Int J Environ Res Public Health Date: 2019-09-05 Impact factor: 3.390
Authors: Masanari Kuwabara; Ichiro Hisatome; Koichiro Niwa; Petter Bjornstad; Carlos A Roncal-Jimenez; Ana Andres-Hernando; Mehmet Kanbay; Richard J Johnson; Miguel A Lanaspa Journal: J Clin Med Date: 2020-03-30 Impact factor: 4.241